HIKALNSEHikal Limited· PharmaceuticalsLowNeutral
Announced Tue, 23 Sept · 21:23 IST

Hikal Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 23, 2025. Further, the company has informed the Exchange regarding voting results.

Board & Shareholder Meetings View source PDF

HIKAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Hikal Limited held its 37th AGM on September 23, 2025, via video conferencing, where shareholders voted on 5 resolutions. All resolutions passed with overwhelming majority, with approval ranging from 99.48% to 99.88% of votes polled. Resolution 1 (adoption of FY25 audited financial statements) passed with 99.48% in favour; Resolution 2 (confirming ₹0.60 interim and declaring ₹0.80 final dividend, totalling ₹1.40 per share for FY25) passed with 99.88% support. Resolution 3 re-appointed Mr. Amit Kalyani as Non-Executive, Non-Independent Director with 99.59% approval. Resolutions 4 (appointment of Secretarial Auditors) and 5 (ratification of Cost Auditors' remuneration for FY26, a special resolution) also passed comfortably. About 77.6% of total equity shares were polled, and 74,134 shareholders attended through video conferencing.

Likely market impact

This is a routine, fully expected outcome with all resolutions passing easily. The confirmed total dividend of ₹1.40 per share is the key shareholder takeaway. No governance surprises or contentious issues — minimal impact on stock price expected.